RETROVIR
250MG CPS DUR 40
SÚKL code | 0180429 |
---|---|
Name of the product | RETROVIR |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | RETROVIR |
Supplement | 250MG CPS DUR 40 |
Strenght | 250MG |
Pharmaceutical form | Capsule, hard |
Package | 40 |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance | ZIDOVUDINE (ZIDOVUDINUM) |
ATC group | J05AF01 |
ATC group name | ZIDOVUDIN |
Marketing authorisation information
Registration Number | 42/ 151/88-C |
---|---|
Type of MA | National |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 31. 05. 2019 |
MA Holder | ViiV Healthcare UK Limited, Brentford |
MA Holder country | VELKÁ BRITÁNIE |
Actual MA holder | ViiV Healthcare BV, Amersfoort |
Actual MA holder country | NIZOZEMSKO |